drugset / Trial / NCT00395239

Asthma/Steroid Withdrawal Study

NCT00395239

Phase 4 Terminated 6 enrolled University of Alberta GlaxoSmithKline · collab
NaSingle-groupOpen-labelTreatment

Summary

The investigators propose to study the patterns of metabolite changes in subjects with asthma to determine if there is a predictable pattern prior to, and post, clinical exacerbation. Hypothesis: 1. Metabolite profiles will change prior to detection of a clinical exacerbation in subjects with asthma. 2\. There will be a measurable temporal delay before metabolite profiles return to baseline following anti-inflammatory therapy of an exacerbation of asthma.

Timeline

Start
2006-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled
Subject Ciclesonide Other / unclassified Inhaled
Subject Fluticasone Other / unclassified Inhaled

Indications